Ayala Pharmaceuticals Inc
General ticker "ADXS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $209.6K
Ayala Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -39.2%.
Estimated limits based on current volatility of 42.8%: low 0.02$, high 0.06$
Factors to consider:
- Current price 93.0% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.38$, 1.89$]
- 2024-12-30 to 2025-12-30 estimated range: [0.41$, 1.93$]
Short-term ADXS quotes
Long-term ADXS plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.01MM |
| Operating Expenses | $36.28MM |
| Operating Income | $-36.27MM |
| Non-Operating Income | $-15.72MM |
| Interest Expense | $15.75MM |
| R&D Expense | $24.08MM |
| Income(Loss) | $-51.98MM |
| Taxes | $-3.91MM |
| Profit(Loss) | $-48.07MM |
| Stockholders Equity | $-24.42MM |
| Assets | $16.58MM |
| Operating Cash Flow | $-29.48MM |
| Investing Cash Flow | $5.95MM |
| Financing Cash Flow | $26.00MM |
| Earnings Per Share* | $-7.99 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.